Publications

5600 Results

Allogeneic Hematopoietic Cell Transplantation Compared to Chemotherapy Consolidation in older Acute Myeloid Leukemia (AML) Patients 60-75 Years in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study

Authors
C Ustun;J Le-Rademacher;H-L Wang;M Othus;Z Sun;B Major;M-J Zhang;E Storrick;J Lafky;S Chow;K Mrozek;E Attar;C Bloomfield;L Cripe;M Tallman;F Appelbaum;S Nand;R Larson;G Marcucci;G Roboz;GL Uy;RM Stone;A Jatoi;T Shea;M di Lima;J Foran;B Sandmaier;M Litzow;H Erba;A Hurria;D Weisdorf;A Artz
Journal / Conference
Leukemia Nov;33(11):2599-2609
Year
2019
Research Committee(s)
Leukemia
PMID
PMID31073153
PMC
PMC6842042
Study Number(s)
S0432, S0703

E1505: Adjuvant Chemotherapy +/- Bevacizumab for early stage NSCLC: Updated chemotherapy subset analysis

Authors
H Wakelee;SE Dahlberg;S Keller;WJ Tester;DR Gandara;S Graziano;A Adjei;N Leighl;CA Butts;S Aisner;J Rothman;J Patel;MD Sborov;S McDermott;R Perez-Soler;A Traynor;TL Evans;S Ramalingam;JH Schiller
Journal / Conference
WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), accepted, mini-oral presentation
Year
2019
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505

A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Lung Cancer

Authors
L Bazhenova;M Redman;S Gettinger;F Hirsch;P Mack;L Schwartz;D Gandara;JD Bradley;T Stinchcombe;N Leighl;S Ramalingam;S Tavernier;K Minichiello;K Kelly;V Papadimitrakopoulou;RS Herbst
Journal / Conference
WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), oral
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400I

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Authors
TD Shanafelt;XV Wang;C Hanson;S O'Brien;J Barrietos;J Barrietos;DF Jelinek;D Braggio;J Leis;CC Zhang;SE Coutre;P Barr;A Cashen;A Mato;A Singh;MP Mullane;RF Little;HP Erba;RM Stone;M Litzow;MS Tallman
Journal / Conference
New England Journal of Medicine Aug 1;381(5):432-443
Year
2019
Research Committee(s)
Leukemia
PMID
PMID31365801
PMC
PMC6908306
Study Number(s)
CTSU/E1912

An Anatomic Classification System for Local Recurrence Following Resection of Intermediate and High Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Trial

Authors
Z Lee;O Jegede;N Haas;M Pins;E Messing;J Manola;C Wood;C Kane;M Jewett;K Flaherty;J Dutcher;R DiPaola;R Uzzo
Journal / Conference
Journal of Urology Vol. 201, No. 4S, Supplement, abst MP14-18, poster (American Urological Association Annual Meeting,May 3-6, 2019, Chicago, IL)
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E2805

CALGB 90203 (ALLIANCE): RADICAL PROSTATECTOMY WITH OR WITHOUT NEOADJUVANT CHEMOHORMONAL THERAPY IN MEN WITH CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER

Authors
JA Eastham;G Heller;S Halabi;JP Monk;H Beltran;M Gleave;CP Evans;S Clinton;R Szmulewitz;J Coleman;D Hillman;C Watt;O Hahn;M Taplin;E Small;J Mohler;MJ Morris
Journal / Conference
American Urological Association Annual Meeting (May 3-6, 2019, Chicago, IL), poster
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/C90203

Clinical Outcomes in Women with Early Breast Cancer and a High 21-Gene Recurrence Score of 26-100 Assigned to Receive Adjuvant Chemotherapy plus Endocrine Therapy: A Secondary Analysis of a Prospective Clinical Trial

Authors
J Sparano;R Gray;D Makower;P Ravdin;K Albain;T Saphner;S Badve;LI Wagner;C Mihalcioiu;C Desbiens;DF Hayes;E Dees;CE Geyer;JA Olson;WC Wood;T Lively;S Paik;MJ Ellis;J Abrams;G Sledge
Journal / Conference
Annals of Oncology 30 (suppl_5): v760-v796; ESMO Congress (Sept 27 - Oct 1, 2019, Barcelona, Spain), LBA, oral
Year
2019
Research Committee(s)
Breast

Next-generation sequencing (NGS) in patients (pts) with metastatic colorectal cancer (mCRC): novel mutated genes and differential response to therapy (Alliance)

Authors
F Innocenti;N Rashid;M Wancen;F-S Ou;X Qu;S Denning;M Bertagnolli;CD Blanke;A Venook;O Kabbarah;H-J Lenz
Journal / Conference
Annals of Oncology 30 (suppl_5): v198-v252; European Society for Medical Oncology (ESMO), (Sept 27-Oct 1, 2019, Barcelona, Spain),
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on the experimental thoracic radiotherapy (TRT) arms of CALGB 30610 (Alliance) / RTOG 0538

Authors
J Bogart;X Wang;G Masters;H Zhu;R Komaki;L Gaspar;J Heymach;M Dobelbower;C Kuzma;T Stinchcombe;E Vokes
Journal / Conference
Annals of Oncology 30 (suppl_5): v710-v717; ESMO Congress (Sept 27-Oct 1, Barcelona, Spain), oral
Year
2019
Research Committee(s)
Lung

Genetic Landscape of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the RATIFY Trial (ALLIANCE C10603)

Authors
N Jahn;E Panina;L Bullinger;A Dolnik;J Herzig;T Blatte;A Benner;J Krzykalla;I Gathmann;RA Larson;F Lo-Coco;S Amadori;T Pryor;J Brandwein;F Appelbaum;B Medeiros;M Tallman;E Tiecke;C Pallaud;G Ehninger;M Heuser;A Ganser;RM Stone;C Thiede;H Dohner;C Bloomfield;K Dohner
Journal / Conference
HemaSphere June; Vol 3, Suppl 1, p 436 (European Hematology Assn Congress, June 13-16, 2019 Amsterdam)
Year
2019
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603